CC BY 4.0 · Rev Bras Ortop (Sao Paulo) 2024; 59(06): e815-e820
DOI: 10.1055/s-0043-1771483
Artigo de Atualização
Oncologia

Update on Conventional Osteosarcoma

Article in several languages: português | English
1   Departamento do Aparelho Locomotor, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brasil
,
2   Grupo de Oncologia Ortopédica, Hospital Santa Izabel, Santa Casa de Misericórdia da Bahia, Salvador, BA, Brasil
,
3   Centro de Sarcomas e Tumores Ósseos, AC Camargo Cancer Center, São Paulo, SP, Brasil
,
4   Grupo de Oncologia Pediátrico, Hospital das Clínicas, Belo Horizonte, MG, Brasil
,
4   Grupo de Oncologia Pediátrico, Hospital das Clínicas, Belo Horizonte, MG, Brasil
› Author Affiliations
Financial Support The authors declare that this study received no specific funding from public, commercial, or not-for-profit sources.
Zoom Image

Abstract

Conventional osteosarcoma is a high-grade malignant tumor characterized by the production of osteoid matrix by malignant osteoblasts. It typically affects the long bones of children and adolescents. Treatment includes systemic chemotherapy and a local surgical approach with wide resection. Recent advances in oncology concepts, imaging, surgical planning, and cancer treatment protocols allow for improved survival and a higher limb preservation rate. This paper addresses the current status regarding the incidence, pathology, treatment, and prognosis of conventional high-grade osteosarcoma.



Publication History

Received: 26 July 2022

Accepted: 27 March 2023

Article published online:
29 January 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil